Shiladitya Sengupta, PhD | American Lung Association

Shiladitya Sengupta, PhD

Research Awards Nationwide Recipient (2013-2015)

Brigham and Women's Hospital, Boston, MA
Funded by the American Lung Association of the Northeast
Using Nanoparticles to Improve Lung Cancer Treatment

Despite advances in molecular understanding of cancer, traditional chemotherapy still relies on highly toxic drugs as first line therapy. As such, there is an urgent need for a new approach in the management of cancer. Using tiny particles [nanoparticles] designed to hone in on specific cancers, Dr. Sengupta and team will try to attach these particles to both standard chemotherapy drugs and the new, more specific, drugs to create a novel and more effective medication.

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.